{
    "nctId": "NCT02840890",
    "briefTitle": "Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast Cancer",
    "officialTitle": "Osteopathy and Prevention of Gastrointestinal Side Effects of the Adjuvant Treatment FEC in Women Treated in Day Hospital for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 94,
    "primaryOutcomeMeasure": "episode of nausea and / or vomiting",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Wife\n* Age over 18 years\n* Operated for a breast cancer stage 1 to 3, in complete resection\n* Plan to receive chemotherapy based on FEC100 3 - 3 TAXOTERE\n* Nurse Consultation prior to chemotherapy\n* planned antiemetic treatment which should include EMEND 125, 80, 80 at J1, J2, J3, ZOPHREN 8 mg IV 1 bulb at J1, Solumedrol 80 mg IV on day 1, Primperan 10 mg 3 tablets a day, from day 1 to day 3, XANAX 0,25 mg 1 tablet morning 1tablet evening from D1 to D3.\n* Distance home CGFL 0 to 50 km, 50 to 100 km, 100 to 200 kms.\n* Having considered the information note\n* written, dated and signed Informed consent\n\nExclusion Criteria:\n\n* Man\n* Metastatic breast cancer\n* Breast cancer surgery with incomplete excision\n* Digestive disorders known or known digestive disease\n* Inability to receive one of the basic elements antibiotic treatment\n* Refusal to participate to the trial\n* Persons deprived of liberty or under guardianship\n* Pregnant woman or likely to be\n* Failure to submit to medical testing for geographical reasons (distance home - CGFL more than 200 km), social or psychic\n* non-affiliation to a social security scheme or to the State Medical Aid (AME) or the universal medical coverage (CMU)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}